Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,640,595
+$1,401,166 QoQ
Shares Held
3,869
+9.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#1,773
of 4,605 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. LLY ranks #1 (48.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,869 | $4,640,595 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,901 | $998,212 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,216 | $670,256 | |
| 4 | BIIB |
Biogen Inc.
|
2,930 | $633,055 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,844 | $624,831 | |
| 6 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 7 | AMGN |
Amgen Inc
|
1,185 | $429,112 | |
| 8 | GRFS |
Grifols SA
|
31,637 | $223,989 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,640,595 | 3,869 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,239,429 | 3,522 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,898,939 | 3,628 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,480,327 | 1,899 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,631,998 | 1,976 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,525,472 | 1,976 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,779,853 | 2,009 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,818,908 | 2,009 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,867,104 | 2,400 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,446,807 | 2,482 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,336,916 | 2,489 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,507,301 | 3,214 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,140,154 | 3,320 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,311,170 | 3,584 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,215,149 | 3,758 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,179,224 | 3,637 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,297,256 | 4,530 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $681,987 | 2,469 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,371,743 | 5,937 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $24,558 | 107 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $12,143 | 65 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||